New MFS-DLPSO-XGBoost AI model achieves 80% precision in cardiovascular risk assessment, endorsed by leading medical organizations as clinical trials show 41% reduction in missed diagnoses. A novel AI...
Exploring how AI and genomics are transforming personalized medicine, from predicting disease risks to optimizing treatments and addressing ethical challenges. AI and genomics are reshaping personaliz...
